Purchase Order HT942523P0071
Award Date
8/16/23
Potential Completion Date
9/22/23
Potential Value
$65K
Funding Federal Agency
Medical Command
Contracting Federal Agency
Defense Health Agency
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics and laboratory equipment. The $106,183.68 contract is for providing blood analysis equipment and associated testing services without any set-aside designation. Roche has received numerous awards from federal agencies, including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services,...
This federal contract award is for a chemistry analyzer from Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $9,280.72 firm fixed-price purchase order was awarded on October 1, 2021 by the Defense Health Agency, with an ultimate completion date of September 30, 2026. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and associated...
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases awarded a $55,800 firm fixed-price purchase order to Roche Diagnostics Corporation for the acquisition of a CEDEX Bio Analyzer. This purchase order is not associated with a set-aside program. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The company has a history of providing critical care analyzers, reagents, test...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $92,853 contract is for the provision of reagents and supplies, with an ultimate completion date of August 9, 2019. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated...
This is a firm fixed-price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the lease of a fully automated chemistry analyzer system with reagents, with a ceiling value of $2,240,104.51 and a period of performance through September 30, 2017. The contract does not have a set-aside designation. Roche Diagnostics has previously received...
This federal contract award to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products, was issued by the Defense Health Agency. The $2,041,453.80 firm-fixed-price delivery order falls under Roche's General Services Administration (GSA) Schedule contract for critical analyzers and laboratory equipment. The contract provides clinical chemistry analyzers, reagents, and testing services to support the Department of Veterans Affairs, Department of...
This federal contract award was issued by the Air Mobility Command (AMC), a defense agency, to Roche Diagnostics Corporation for the delivery of a Roche analyzer for immunochemistry testing. The $450,472.95 firm-fixed-price delivery order was placed against Roche's existing GSA Schedule 66 contract for critical laboratory analyzers. The contract has a completion date of September 30, 2016 and does not utilize any set-aside designations. Roche Diagnostics is a manufacturer and distributor of in...
This is a firm fixed-price purchase order award by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $27,000.00 base year contract is for preventive maintenance and repair services on medical equipment. The award is not set aside for small businesses. Roche Diagnostics holds several significant Indefinite Delivery Vehicle (IDV) contracts and Blanket Purchase Agreements (BPAs)...
This is a firm-fixed price delivery order awarded to Roche Diagnostics Corporation by the Defense Medical Command (MEDCOM) of the U.S. Army on September 1, 2015. The contract, valued at $3,082,805.38, is to provide chemistry reagents under the General Services Administration (GSA) Schedule contract for Critical Analyzers and Laboratory Equipment (FSS-66-III). The contract does not have a set-aside designation. Roche Diagnostics, as the prime contractor, will deliver the chemistry reagents to...
The U.S. Department of the Air Force awarded a delivery order contract worth $341,648.46 to Roche Diagnostics Corporation for the provision of a chemistry analyzer and associated reagents. This award was made through Roche's existing General Services Administration (GSA) Schedule 66 contract for Critical Analyzers and Laboratory Equipment. The contract does not have a set-aside designation. Roche Diagnostics Corporation is a foreign-owned, for-profit manufacturer and distributor of in vitro...